Mutant p53 expressed in many types of carcinoma lacks an inhibitory fu
nction on cell. growth, but its role has been unclear. We performed tw
o-parameter flow cytometry (FCM) to elucidate the relationship between
the expression of p53 and the cell cycle in A431 cells. Fluorescence
in situ hybridization proved that an A431 cell had two p53 genes where
as chromosome 17 was tetraploid. FCM showed that A431 cells expressed
constantly high levels of p53 during the cell cycle. Under conditions
of both serum deprivation and presence of hydroxyurea, p53 expression
was decreased throughout the cell cycle, and the bivariate DNA/p53 dis
tribution pattern during the cell cycle did not change. The expression
of p53 was reduced to 60% for the first 4 h after the addition of cyc
loheximide, and showed no significant changes at least for 20 h. Treat
ment with Triton X-100 increased p53 immunoreactivity throughout the c
ell cycle. These results indicate that mutant p53 differs from prolife
rative markers such as PCNA, Ki-67 and DNA polymerase-a, and that ther
e are no links between the expression of p53 and the cell cycle in A43
1 cells.